Jun 15, 2026 06:50AM
Jun 15, 2026 06:50AM
May 12, 2026 04:05PM
May 8, 2026 06:01AM
May 8, 2026 06:00AM
Apr 20, 2026 06:50AM
Apr 20, 2026 06:50AM Evidence Supporting Combined Use of Deucrictibant IR with Deucrictibant XR Presented at CIIC Spring 2026 Conference
Apr 2, 2026 06:50AM
Mar 20, 2026 06:51AM
Mar 20, 2026 06:50AM
Mar 11, 2026 06:50AM
Mar 11, 2026 06:50AM
Mar 11, 2026 06:50AM
Mar 2, 2026 06:55AM Pharvaris presents deucrictibant data at allergy conference
Mar 2, 2026 06:50AM
Jan 12, 2026 06:50AM
Jan 12, 2026 06:50AM
Dec 3, 2025 06:50AM
Dec 3, 2025 06:50AM
Nov 12, 2025 06:50AM
Nov 10, 2025 06:50AM Data Supporting the Potentially Differentiated Pharvaris Portfolio Presented at ACAAI 2025 Annual Scientific Meeting
Aug 12, 2025 04:05PM
Jul 10, 2025 06:51AM
Jul 10, 2025 06:50AM
Jun 16, 2025 06:50AM
Jun 16, 2025 06:50AM
Jun 2, 2025 06:52AM
Jun 2, 2025 06:50AM Pharvaris Presents Data Supporting Ongoing Clinical Development of Deucrictibant in Bradykinin-Mediated Angioedema
May 13, 2025 04:05PM
Apr 7, 2025 06:58AM
Apr 1, 2025 06:50AM
Apr 1, 2025 06:50AM
Mar 3, 2025 06:50AM
Mar 3, 2025 06:50AM
Jan 13, 2025 06:52AM Pharvaris (PHVS) Outlines 2025 Strategic Priorities
Jan 13, 2025 06:50AM
Nov 13, 2024 04:10PM
Oct 24, 2024 08:00AM
Sep 5, 2024 06:50AM
Sep 5, 2024 06:50AM
Sep 5, 2024 06:50AM
Sep 5, 2024 06:49AM Pharvaris Presents Deucrictibant Long-Term Extension Data for Both the Prophylactic and On-Demand Treatment of HAE at the Bradykinin Symposium 2024
Sep 5, 2024 06:48AM
Aug 14, 2024 06:50AM
Aug 1, 2024 08:00AM
Jun 4, 2024 06:50AM
May 14, 2024 02:20AM
May 8, 2024 04:10PM
Apr 10, 2024 04:10PM Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Apr 10, 2024 04:09PM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All